Other bulletins in this series include:

Breast Surgery

Showing posts with label acute liver failure. Show all posts
Showing posts with label acute liver failure. Show all posts

Tuesday, 25 February 2020

Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations


Objectives: 
To develop evidence-based recommendations for clinicians caring for adults with acute or acute on chronic liver failure in the ICU.
Design: 
The guideline panel comprised 29 members with expertise in aspects of care of the critically ill patient with liver failure and/or methodology. The Society of Critical Care Medicine standard operating procedures manual and conflict-of-interest policy were followed throughout. Teleconferences and electronic-based discussion among the panel, as well as within subgroups, served as an integral part of the guideline development.
Setting: 
The panel was divided into nine subgroups: cardiovascular, hematology, pulmonary, renal, endocrine and nutrition, gastrointestinal, infection, perioperative, and neurology.
Interventions: 
We developed and selected population, intervention, comparison, and outcomes questions according to importance to patients and practicing clinicians. For each population, intervention, comparison, and outcomes question, we conducted a systematic review aiming to identify the best available evidence, statistically summarized the evidence whenever applicable, and assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence to decision framework to facilitate recommendations formulation as strong or conditional. We followed strict criteria to formulate best practice statements.
Measurements and Main Results: 
In this article, we report 29 recommendations (from 30 population, intervention, comparison, and outcomes questions) on the management acute or acute on chronic liver failure in the ICU, related to five groups (cardiovascular, hematology, pulmonary, renal, and endocrine). Overall, six were strong recommendations, 19 were conditional recommendations, four were best-practice statements, and in two instances, the panel did not issue a recommendation due to insufficient evidence.
Conclusions: 
Multidisciplinary international experts were able to formulate evidence-based recommendations for the management acute or acute on chronic liver failure in the ICU, acknowledging that most recommendations were based on low-quality indirect evidence.

The exsecutive summary can be found here: https://journals.lww.com/ccmjournal/Fulltext/2020/03000/Guidelines_for_the_Management_of_Adult_Acute_and.17.aspx


Tuesday, 22 October 2019

Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials


Alshamsi, F., Alshammari, K., Belley-Cote, E. et al. Intensive Care Med (2019).

First online: 07.10.2019

Purpose
Acute liver failure (ALF) and acute on chronic liver failure (ACLF) are associated with significant mortality and morbidity. Extracorporeal liver support (ECLS) devices have been used as a bridge to liver transplant; however, the efficacy and safety of ECLS are unclear. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to examine the efficacy and safety of ECLS in liver failure.
Methods
We searched MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials from inception through March 13, 2019. RCTs comparing ECLS to usual care in ALF or ACLF were included. We used the Grading of Recommendations Assessment, Development and Evaluation approach to assess the certainty of the evidence.
Results
We identified 25 RCTs (1796 patients). ECLS use was associated with reduction in mortality (RR 0.84; 95% CI 0.74, 0.96, moderate certainty) and improvement in hepatic encephalopathy (HE) (RR 0.71; 95% CI 0.60, 0.84, low certainty) in patients with ALF or ACLF. The effect of ECLS on hypotension (RR 1.46; 95% CI 0.98, 2.2, low certainty), bleeding (RR 1.21; 95% CI 0.88, 1.66, moderate certainty), thrombocytopenia (RR 1.62; 95% CI 1.0, 2.64, very low certainty) and line infection (RR 1.92; 95% CI 0.11, 33.44, low certainty) was uncertain.
Conclusions

ECLS may reduce mortality and improve HE in patients with ALF and ACLF. The effect on other outcomes is uncertain. However, the evidence is limited by risk of bias and imprecision, and larger trials are needed to better determine the effect of ECLS on patient-important outcomes.

Tuesday, 23 December 2008

Sepsis articles: Journal of Critical Care

JOURNAL OF CRITICAL CARE
VOL 23; NUMBER 4; 2008 ISSN 0883-9441

pp. 452-453
It is time to label sepsis as a public health problem.
Ibrahim, I.
http://zetoc.mimas.ac.uk/wzgw?db=etoc&terms=RN241197813&field=zid

pp. 455-460
Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: We could go faster.
Zambon, M.; Ceola, M.; Almeida-de-Castro, R.; Gullo, A.; Vincent, J. L.
http://zetoc.mimas.ac.uk/wzgw?db=etoc&terms=RN241197837&field=zid

pp. 461-467
Intra-abdominal hypertension: Incidence and association with organ dysfunction during early septic shock.
Regueira, T.; Bruhn, A.; Hasbun, P.; Aguirre, M.; Romero, C.; Llanos, O.; Castro, R.; Bugedo, G.; Hernandez, G.
http://zetoc.mimas.ac.uk/wzgw?db=etoc&terms=RN241197840&field=zid

pp. 468-472
Hemodynamics and metabolic studies on septic shock in patients with acute liver failure.
Tsai, M. H.; Chen, Y. C.; Lien, J. M.; Tian, Y. C.; Peng, Y. s.; Fang, J. T.; Yang, C.; Tang, J. H.; Chu, Y. Y.; Chen, P. C.
http://zetoc.mimas.ac.uk/wzgw?db=etoc&terms=RN241197851&field=zid

pp. 475-483
Sepsis and organ system failure are major determinants of post–intensive care unit mortality.
Sakr, Y.; Vincent, J. L.; Ruokonen, E.; Pizzamiglio, M.; Installe, E.; Reinhart, K.; Moreno, R.;
http://zetoc.mimas.ac.uk/wzgw?db=etoc&terms=RN241197876&field=zid